Advisory Services Network’s Corbus Pharmaceuticals CRBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$844K Buy
89,951
+89,937
+642,407% +$851K 0.01% 1104
2026
Q1
$131 Buy
+14
New +$118 ﹤0.01% 4642
2025
Q4
Sell
-14
Closed -$177 2316
2025
Q3
$177 Buy
+14
New +$133 ﹤0.01% 4236
2021
Q1
Sell
-233
Closed -$9K 1609
2020
Q4
$9K Buy
233
+200
+606% +$7.48K ﹤0.01% 2467
2020
Q3
$2K Buy
+33
New +$5.98K ﹤0.01% 3085

Other funds holding CRBP

Advisory Services Network's CRBP Position: Q2 2026 in Review

Advisory Services Network increased its Corbus Pharmaceuticals (CRBP) stake by 642,407% in Q2 2026, buying an estimated $851K and bringing the position to 89,951 shares worth $844K. The position accounts for 0.01% of the portfolio, ranked #1104.

Advisory Services Network first reported a position in CRBP in Q3 2020 and has held it in 5 quarters since. 107 funds tracked by Wall St. Rank hold CRBP as of Q2 2026.

  • Advisory Services Network held 89,951 shares of Corbus Pharmaceuticals worth $844K as of Q2 2026.
  • Advisory Services Network bought 89,937 Corbus Pharmaceuticals shares in Q2 2026, an estimated $851K.
  • Corbus Pharmaceuticals made up 0.01% of Advisory Services Network's portfolio in Q2 2026, its #1104 holding.
  • Advisory Services Network first reported a position in Corbus Pharmaceuticals in Q3 2020 and has held it in 5 quarters since.
  • 107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.